Two more recent studies, using next-generation sequencing, confirmed recurrent mutations in MM PC that either result in downregulation or loss of function of NFκB negative regulators, or overexpression or gain of function of positive NFκB regulators [6,7]. This evidence concerns the gene NFKB1 and Miyoshi myopathy.